Clinical Trial Update: TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) [Phase 1, Phase 2]

View source ↗

Summary

An update on the Phase 1/2 trial of TDI01 for chronic graft-versus-host disease, noting a recruitment suspension and current status as active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• TDI01

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: GVHD, Chronic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING